Canopy Growth (CGC) Non-Current Assets (2017 - 2025)
Canopy Growth's (CGC) quarterly Non-Current Assets came in at $417.0 million in Q4 2025, up 16.16% year-on-year from $359.0 million in Q4 2024, and down 8.03% quarter-over-quarter from $453.4 million in Q3 2025.
Canopy Growth (CGC) Non-Current Assets (2017 - 2025) Analysis & Trends
Canopy Growth has disclosed Non-Current Assets across 9 years of filings, most recently posting $417.0 million for Q4 2025.
- Non-Current Assets for Q4 2025 came in at $417.0 million, up 16.16% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.7 billion (down 29.55% YoY), and the FY2025 annual result was $204.6 million, down 13.89% from the prior year.
- Non-Current Assets came in at $417.0 million for Q4 2025 at Canopy Growth, down from $453.4 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.4 billion in Q3 2022 to a low of $204.6 million in Q1 2025.
- The 5-year median for Non-Current Assets is $716.8 million (2023), against an average of $700.4 million.
- Peak annual rise in Non-Current Assets reached 4359.66% in 2021, while the deepest fall reached 72.23% in 2021.
- Canopy Growth's Non-Current Assets stood at $856.9 million in 2021, then jumped by 53.87% to $1.3 billion in 2022, then slumped by 46.38% to $707.0 million in 2023, then tumbled by 49.22% to $359.0 million in 2024, then increased by 16.16% to $417.0 million in 2025.
- The last three Non-Current Assets figures came in at $417.0 million (Q4 2025), $453.4 million (Q3 2025), and $434.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | 417.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 417.00 Mn |
| Sep 30, 2025 | 453.44 Mn |
| Jun 30, 2025 | 433.97 Mn |
| Mar 31, 2025 | 204.56 Mn |
| Dec 31, 2024 | 358.98 Mn |
| Sep 30, 2024 | 616.27 Mn |
| Jun 30, 2024 | 678.82 Mn |
| Mar 31, 2024 | 237.55 Mn |
| Dec 31, 2023 | 706.97 Mn |
| Sep 30, 2023 | 876.12 Mn |
| Jun 30, 2023 | 973.23 Mn |
| Mar 31, 2023 | 348.60 Mn |
| Dec 31, 2022 | 1.32 Bn |
| Sep 30, 2022 | 1.39 Bn |
| Jun 30, 2022 | 726.59 Mn |
| Mar 31, 2022 | 744.30 Mn |
| Dec 31, 2021 | 856.94 Mn |
| Sep 30, 2021 | 892.38 Mn |
| Jun 30, 2021 | 929.55 Mn |
| Mar 31, 2021 | 848.99 Mn |